By controlling PPP2R1B, a downstream target of miR-224-5p, and CPEB3, the miR-224-5p overexpression promoted HCC cell motility and invasion, according to several studies (58–60). The gene discussed is PPP2R1B; the disease is hepatocellular carcinoma.